Medicated Shampoo Products Market Size, Share, & Trends Analysis Report (2023 – 2030)

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Report Overview

The global medicated shampoo market was valued at USD 6.03 billion in 2022 and is projected to expand at a CAGR of 5.3% from 2023 to 2030. Increasing global awareness of personal hygiene and the rising prevalence of scalp and hair disorders are some of the major factors driving the growth of the market. Furthermore, the rising demand for anti-dandruff and anti-hair fall shampoos owing to their therapeutic effects on the hair is further propelling the market growth.

The rising demand for organic and natural ingredients-based products is increasing the demand for medicated shampoo products. For instance, in April 2021, Johnson & Johnson launched a new line of products called ‘No More Tears’, which is a range of natural baby shampoos and body washes, free from sulfates and parabens. Moreover, the increasing demand from consumers for products free from artificial ingredients and preservatives is further driving the market growth.

The increasing influence of social media and the growing awareness about the benefits of medicated shampoos are some of the other factors driving the market growth. The growing demand for medicated shampoos from men is further augmenting the market growth. The increasing focus of manufacturers on product innovations and the rising number of product launches are expected to drive the market further in the coming years.

Furthermore, the growing prevalence of scalp and hair disorders is increasing the demand for medicated shampoos across the globe. For instance, according to an article published by the American Academy of Dermatology in July 2019, dandruff is a common scalp condition that affects almost half of the population. Moreover, the rising demand for premium medicated shampoos has forced manufacturers to introduce innovative products with premium pricing. This has further driven the market growth.

Product Insights

The medicated shampoo segment held the largest market share in 2020. Medicated shampoos are used regularly to treat issues such as scalp irritation, dandruff, hair loss, and other scalp infections. According to an article published by the University of Edinburgh, in February 2020, the global medicated shampoo market is driven mainly by the launch of new products that offer better performance and convenience. Increasing health awareness, changing lifestyle, and rising disposable income are also driving the demand for medicated shampoos.

The anti-dandruff shampoo segment is projected to register the highest CAGR during the forecast period. The rising prevalence of scalp disorders, such as dandruff and seborrheic dermatitis, is driving the growth of the anti-dandruff shampoo segment. According to an article published by the University of Edinburgh, in February 2020, the rising demand for anti-dandruff shampoos is attributed to the increasing prevalence of dandruff and other scalp disorders. Furthermore, the increasing awareness among consumers regarding the importance of healthy hair and scalp is also driving the demand for anti-dandruff shampoos.

Distribution Channel Insights

The pharmacies and drug stores segment accounted for the largest market share of over 32.6% in 2022. The growth of the segment is mainly attributed to the rising awareness among consumers regarding the availability of medicated shampoo products in pharmacies or drug stores, thus driving their sales. The increasing popularity of medicated shampoos among consumers is also driving the growth of the segment. Additionally, the easy availability of medicated shampoos in pharmacies or drug stores has enabled consumers to purchase the products according to their convenience.

The online segment is expected to register the highest CAGR of 14.1% during the forecast period. The growth of the segment is attributed to the increasing internet penetration coupled with the availability of a wide range of medicated shampoos through e-commerce websites. Furthermore, the rising popularity of online retailing among consumers is likely to drive the demand for medicated shampoos. For instance, in December 2022, Nykaa launched a dedicated medicated shampoo category on its website. This category offers a wide range of products from the best brands in the market.

Type Insights

The medicated shampoo segment accounted for the largest revenue share of 73.7% in the year 2022. The growing prevalence of scalp and hair disorders and the increasing awareness of the scalp and hair care products are the major factors driving the demand for medicated shampoos. Furthermore, the availability of a wide range of medicated shampoos that address various scalp and hair issues is also driving the growth of the market. For instance, Johnson & Johnson, a well-known manufacturer of medicated shampoos, produces a wide range of products such as Head & Shoulders, Selsun Blue, and Neutrogena T/Sal. These products help in treating scalp issues such as dandruff, psoriasis, and seborrheic dermatitis.

The natural shampoo segment is estimated to expand at the highest CAGR of 10.9% over the forecast period. The increasing awareness about the usage of natural ingredients and the rise in demand for organic and natural products are the major factors driving the growth of the natural shampoo segment. Furthermore, the growing inclination towards the use of natural and organic ingredients in the personal care products has increased the demand for natural shampoos. Moreover, the rising trend of using natural products among young people has further boosted the demand for natural shampoos.

Regional Insights

Asia Pacific is expected to be the largest medicated shampoo market and will dominate the global market during the forecast period. This is attributed to the increasing urbanization, rising disposable income, and lifestyle changes among consumers. The rising prevalence of skin and scalp-related problems such as dandruff, scalp psoriasis, and excessive oiliness is also driving the market in the region. In India, anti-dandruff shampoos account for the largest category for medicated shampoos, with a market share of over 60%.

In Europe, the market is expected to witness steady growth on account of increasing awareness regarding the benefits of medicated shampoos among consumers. The increasing preference for natural and organic products is also driving the market in the region. The Netherlands, France, and the UK are the major markets in the region and are expected to generate significant demand in the coming years. Germany is also expected to witness considerable growth due to the rising awareness regarding personal hygiene among consumers.

Financial Projections

In this part of the medicated shampoo products business plan, we will provide a detailed breakdown of all income and expense categories of the business. These forecasts include cash flow projections and capital requirements for your medicated shampoo products. Usually, these projections are drafted for a 5-year period.

Revenue Assumptions

The main source of revenues for a medicated shampoo products business comes from sales of the products, possible endorsements, and sponsorships. Here you will find a list with a description of each of them and other possible sources of profit such as the sale of related merchandise, licensing the products for use in other industries, and research and development for new products.

Projecting Expenses

In this section, all the regular expenses related to keeping the medicated shampoo products business running will be described. The list of operating expenses includes manufacturing costs, raw material costs, packaging costs, R&D costs, advertising and promotion, wages, utilities, rent, insurance policies, and others.

Key companies & market share insights

Some of the key companies operating in the medicated shampoo market are continuously focusing on product launches and expansion of the distribution channel to gain prominent visibility among consumers. Some of the initiatives are:

– In June 2022, Unilever launched the Clear Men Scalp Therapy Shampoo specifically designed to treat dandruff and other scalp conditions.

– In August 2022, Head & Shoulders launched a new line of shampoos for men, which is specifically designed to treat dandruff and other scalp conditions.

– In October 2022, L’Oréal Paris launched a new line of medicated shampoos targeting scalp health and hair growth.

Some of the prominent players in the medicated shampoo market include:

– Unilever
– Procter & Gamble
– L’Oréal Paris
– Head & Shoulders
– Johnson & Johnson
– Kao Corporation
– Church & Dwight Co., Inc.
– GlaxoSmithKline plc
– Henkel AG & Co. KGaA
– Synergy Laboratories, Inc.

Global Medicated Shampoo Market Segmentation

This report forecasts growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global medicated shampoo products market based on product, distribution channel, type, and region:

1. Product Outlook (Revenue, USD Million, 2017 – 2030)

– Antibacterial
– Anti-Dandruff
– Anti-Hair Loss
– Others

2. Distribution Channel Outlook (Revenue, USD Million, 2017 – 2030)

– Supermarkets & Hypermarkets
– Online
– Others

3. Type Outlook (Revenue, USD Million, 2017 – 2030)
– Mass
– Premium

4. Regional Outlook (Revenue, USD Million, 2017 – 2030)

– North America
– Europe
– Asia Pacific
– Central & South America
– Middle East & Africa

Frequently Asked Questions

[Q]: What is the Potential of Product Innovation in the Medicated Shampoo Market?
[A]: The potential of product innovation in the medicated shampoo market is high, as advances in technology and materials have brought new formulations and applications to the market. Companies are now creating shampoos with a range of specialized benefits and ingredients, such as anti-dandruff, scalp therapy, and even shampoos that are specifically formulated for color-treated hair. In addition, companies are also experimenting with natural ingredients to create more eco-friendly medicated shampoos.

[Q]: Who are the Key Players in the Medicated Shampoo Market?
[A]: The key players in the medicated shampoo market include Procter & Gamble Co., Unilever Plc., Johnson & Johnson, L’Oréal SA, and Kao Corporation.

[Q]: Which Region Offers the Largest Opportunity for Sales of Medicated Shampoo?
[A]: Asia-Pacific is expected to be the largest market for medicated shampoo, owing to the increasing demand from countries such as China, Japan, and India. The growing demand for anti-dandruff and scalp therapy shampoos in developed markets, coupled with the rising disposable incomes in developing countries, are expected to drive the market.

[Q]: What are the factors driving the Medicated Shampoo market?
[A]: Factors such as rising consumer awareness regarding personal hygiene, increased spending on personal care products, the growing demand for specialized shampoos, and the introduction of novel products are expected to drive the market over the forecast period.

image_pdf

Medicated Shampoo Products Market Size, Share, & Trends Analysis Report (2023 – 2030)

Report Overview

The global medicated shampoo market was valued at USD 6.03 billion in 2022 and is projected to expand at a CAGR of 5.3% from 2023 to 2030. Increasing global awareness of personal hygiene and the rising prevalence of scalp and hair disorders are some of the major factors driving the growth of the market. Furthermore, the rising demand for anti-dandruff and anti-hair fall shampoos owing to their therapeutic effects on the hair is further propelling the market growth.

The rising demand for organic and natural ingredients-based products is increasing the demand for medicated shampoo products. For instance, in April 2021, Johnson & Johnson launched a new line of products called ‘No More Tears’, which is a range of natural baby shampoos and body washes, free from sulfates and parabens. Moreover, the increasing demand from consumers for products free from artificial ingredients and preservatives is further driving the market growth.

The increasing influence of social media and the growing awareness about the benefits of medicated shampoos are some of the other factors driving the market growth. The growing demand for medicated shampoos from men is further augmenting the market growth. The increasing focus of manufacturers on product innovations and the rising number of product launches are expected to drive the market further in the coming years.

Furthermore, the growing prevalence of scalp and hair disorders is increasing the demand for medicated shampoos across the globe. For instance, according to an article published by the American Academy of Dermatology in July 2019, dandruff is a common scalp condition that affects almost half of the population. Moreover, the rising demand for premium medicated shampoos has forced manufacturers to introduce innovative products with premium pricing. This has further driven the market growth.

Product Insights

The medicated shampoo segment held the largest market share in 2020. Medicated shampoos are used regularly to treat issues such as scalp irritation, dandruff, hair loss, and other scalp infections. According to an article published by the University of Edinburgh, in February 2020, the global medicated shampoo market is driven mainly by the launch of new products that offer better performance and convenience. Increasing health awareness, changing lifestyle, and rising disposable income are also driving the demand for medicated shampoos.

The anti-dandruff shampoo segment is projected to register the highest CAGR during the forecast period. The rising prevalence of scalp disorders, such as dandruff and seborrheic dermatitis, is driving the growth of the anti-dandruff shampoo segment. According to an article published by the University of Edinburgh, in February 2020, the rising demand for anti-dandruff shampoos is attributed to the increasing prevalence of dandruff and other scalp disorders. Furthermore, the increasing awareness among consumers regarding the importance of healthy hair and scalp is also driving the demand for anti-dandruff shampoos.

Distribution Channel Insights

The pharmacies and drug stores segment accounted for the largest market share of over 32.6% in 2022. The growth of the segment is mainly attributed to the rising awareness among consumers regarding the availability of medicated shampoo products in pharmacies or drug stores, thus driving their sales. The increasing popularity of medicated shampoos among consumers is also driving the growth of the segment. Additionally, the easy availability of medicated shampoos in pharmacies or drug stores has enabled consumers to purchase the products according to their convenience.

The online segment is expected to register the highest CAGR of 14.1% during the forecast period. The growth of the segment is attributed to the increasing internet penetration coupled with the availability of a wide range of medicated shampoos through e-commerce websites. Furthermore, the rising popularity of online retailing among consumers is likely to drive the demand for medicated shampoos. For instance, in December 2022, Nykaa launched a dedicated medicated shampoo category on its website. This category offers a wide range of products from the best brands in the market.

Type Insights

The medicated shampoo segment accounted for the largest revenue share of 73.7% in the year 2022. The growing prevalence of scalp and hair disorders and the increasing awareness of the scalp and hair care products are the major factors driving the demand for medicated shampoos. Furthermore, the availability of a wide range of medicated shampoos that address various scalp and hair issues is also driving the growth of the market. For instance, Johnson & Johnson, a well-known manufacturer of medicated shampoos, produces a wide range of products such as Head & Shoulders, Selsun Blue, and Neutrogena T/Sal. These products help in treating scalp issues such as dandruff, psoriasis, and seborrheic dermatitis.

The natural shampoo segment is estimated to expand at the highest CAGR of 10.9% over the forecast period. The increasing awareness about the usage of natural ingredients and the rise in demand for organic and natural products are the major factors driving the growth of the natural shampoo segment. Furthermore, the growing inclination towards the use of natural and organic ingredients in the personal care products has increased the demand for natural shampoos. Moreover, the rising trend of using natural products among young people has further boosted the demand for natural shampoos.

Regional Insights

Asia Pacific is expected to be the largest medicated shampoo market and will dominate the global market during the forecast period. This is attributed to the increasing urbanization, rising disposable income, and lifestyle changes among consumers. The rising prevalence of skin and scalp-related problems such as dandruff, scalp psoriasis, and excessive oiliness is also driving the market in the region. In India, anti-dandruff shampoos account for the largest category for medicated shampoos, with a market share of over 60%.

In Europe, the market is expected to witness steady growth on account of increasing awareness regarding the benefits of medicated shampoos among consumers. The increasing preference for natural and organic products is also driving the market in the region. The Netherlands, France, and the UK are the major markets in the region and are expected to generate significant demand in the coming years. Germany is also expected to witness considerable growth due to the rising awareness regarding personal hygiene among consumers.

Financial Projections

In this part of the medicated shampoo products business plan, we will provide a detailed breakdown of all income and expense categories of the business. These forecasts include cash flow projections and capital requirements for your medicated shampoo products. Usually, these projections are drafted for a 5-year period.

Revenue Assumptions

The main source of revenues for a medicated shampoo products business comes from sales of the products, possible endorsements, and sponsorships. Here you will find a list with a description of each of them and other possible sources of profit such as the sale of related merchandise, licensing the products for use in other industries, and research and development for new products.

Projecting Expenses

In this section, all the regular expenses related to keeping the medicated shampoo products business running will be described. The list of operating expenses includes manufacturing costs, raw material costs, packaging costs, R&D costs, advertising and promotion, wages, utilities, rent, insurance policies, and others.

Key companies & market share insights

Some of the key companies operating in the medicated shampoo market are continuously focusing on product launches and expansion of the distribution channel to gain prominent visibility among consumers. Some of the initiatives are:

– In June 2022, Unilever launched the Clear Men Scalp Therapy Shampoo specifically designed to treat dandruff and other scalp conditions.

– In August 2022, Head & Shoulders launched a new line of shampoos for men, which is specifically designed to treat dandruff and other scalp conditions.

– In October 2022, L’Oréal Paris launched a new line of medicated shampoos targeting scalp health and hair growth.

Some of the prominent players in the medicated shampoo market include:

– Unilever
– Procter & Gamble
– L’Oréal Paris
– Head & Shoulders
– Johnson & Johnson
– Kao Corporation
– Church & Dwight Co., Inc.
– GlaxoSmithKline plc
– Henkel AG & Co. KGaA
– Synergy Laboratories, Inc.

Global Medicated Shampoo Market Segmentation

This report forecasts growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global medicated shampoo products market based on product, distribution channel, type, and region:

1. Product Outlook (Revenue, USD Million, 2017 – 2030)

– Antibacterial
– Anti-Dandruff
– Anti-Hair Loss
– Others

2. Distribution Channel Outlook (Revenue, USD Million, 2017 – 2030)

– Supermarkets & Hypermarkets
– Online
– Others

3. Type Outlook (Revenue, USD Million, 2017 – 2030)
– Mass
– Premium

4. Regional Outlook (Revenue, USD Million, 2017 – 2030)

– North America
– Europe
– Asia Pacific
– Central & South America
– Middle East & Africa

Frequently Asked Questions

Menu